SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Syschem (India) - Quaterly Results

08 Nov 2024 Evaluate
The Revenue for the quarter ended  September 2024 of Rs. 542.07 millions grew by 24.11 % from Rs. 436.78 millions.The Net Loss for the quarter ended September 2024 is Rs. -6.40 millions as compared to Net Profit of Rs. 11.18 millions of corresponding quarter ended September 2023The company reported a degrowth in operating Profit to 0.69 millions from 18.48 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 542.07 436.78 24.11 1563.59 939.64 66.40 2334.77 1303.77 79.08
Other Income 0.00 0.02 -100.00 0.09 0.07 28.57 1.70 2.48 -31.45
PBIDT 0.69 18.48 -96.27 8.88 43.05 -79.37 71.54 88.96 -19.58
Interest 0.30 0.31 -3.23 0.33 1.35 -75.56 2.53 0.42 502.38
PBDT 0.39 18.17 -97.85 8.55 41.70 -79.50 69.01 88.54 -22.06
Depreciation 6.79 6.99 -2.86 13.58 13.75 -1.24 27.89 27.03 3.18
PBT -6.40 11.18 -157.25 -5.03 27.95 -118.00 41.12 61.51 -33.15
TAX 0.00 0.00 0.00 0.00 0.00 0.00 13.52 16.38 -17.46
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 13.52 16.38 -17.46
PAT -6.40 11.18 -157.25 -5.03 27.95 -118.00 27.60 45.13 -38.84
Equity 398.63 318.90 25.00 398.63 318.90 25.00 398.63 318.90 25.00
PBIDTM(%) 0.13 4.23 -96.99 0.57 4.58 -87.60 3.06 6.82 -55.09

Syschem (India) Share Price

52.87 0.74 (1.42%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×